PANG.MC
Price:
$1.7
Market Cap:
$58.04M
Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. It also provides biomarker disc...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-09-19
Stock Exchange
BME
Ticker
PANG.MC
According to Pangaea Oncology, S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 60.31M. This represents a change of 15.67% compared to the average of 52.14M of the last 4 quarters.
The mean historical Enterprise Value of Pangaea Oncology, S.A. over the last ten years is 38.88M. The current 60.31M Enterprise Value has changed 15.41% with respect to the historical average. Over the past ten years (40 quarters), PANG.MC's Enterprise Value was at its highest in in the December 2024 quarter at 63.00M. The Enterprise Value was at its lowest in in the December 2016 quarter at -216910.00.
Average
38.88M
Median
37.01M
Minimum
26.70M
Maximum
63.00M
Discovering the peaks and valleys of Pangaea Oncology, S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 39.02%
Maximum Annual Enterprise Value = 63.00M
Minimum Annual Increase = -11.04%
Minimum Annual Enterprise Value = 26.70M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 63.00M | 29.47% |
| 2023 | 48.66M | 18.27% |
| 2022 | 41.14M | 5.07% |
| 2021 | 39.16M | 6.13% |
| 2020 | 36.90M | 13.47% |
| 2019 | 32.52M | -3.29% |
| 2018 | 33.62M | -9.42% |
| 2017 | 37.12M | 39.02% |
| 2016 | 26.70M | -11.04% |
| 2015 | 30.01M | 2.27% |
The current Enterprise Value of Pangaea Oncology, S.A. (PANG.MC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
50.93M
5-year avg
45.77M
10-year avg
38.88M
Pangaea Oncology, S.A.’s Enterprise Value is
| Company | Enterprise Value | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pangaea Oncology, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pangaea Oncology, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pangaea Oncology, S.A.'s Enterprise Value?
What is the highest Enterprise Value for Pangaea Oncology, S.A. (PANG.MC)?
What is the 3-year average Enterprise Value for Pangaea Oncology, S.A. (PANG.MC)?
What is the 5-year average Enterprise Value for Pangaea Oncology, S.A. (PANG.MC)?
How does the current Enterprise Value for Pangaea Oncology, S.A. (PANG.MC) compare to its historical average?